SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-225746
Filing Date
2012-05-10
Accepted
2012-05-10 16:38:47
Documents
12
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d345961d10q.htm 10-Q 454736
2 STOCK PURCHASE AGREEMENT d345961dex27.htm EX-2.7 296495
3 SECTION 302 CEO CERTIFICATION d345961dex311.htm EX-31.1 9615
4 SECTION 302 CFO CERTIFICATION d345961dex312.htm EX-31.2 9601
5 SECTION 906 CEO CERTIFICATION d345961dex321.htm EX-32.1 2466
6 SECTION 906 CFO CERTIFICATION d345961dex322.htm EX-32.2 2440
  Complete submission text file 0001193125-12-225746.txt   2746494

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT opk-20120331.xml EX-101.INS 321390
8 XBRL TAXONOMY EXTENSION SCHEMA opk-20120331.xsd EX-101.SCH 11662
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE opk-20120331_cal.xml EX-101.CAL 44652
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE opk-20120331_def.xml EX-101.DEF 27502
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE opk-20120331_lab.xml EX-101.LAB 143435
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE opk-20120331_pre.xml EX-101.PRE 91551
Mailing Address 4400 BISCAYNE BLVD. SUITE 900 MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. SUITE 900 MIAMI FL 33137 305-575-6015
Opko Health, Inc. (Filer) CIK: 0000944809 (see all company filings)

IRS No.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33528 | Film No.: 12830847
SIC: 2834 Pharmaceutical Preparations